Yellapragada Subbarao

Yellapragada Subbarao
Indian Scientist
Born	12 January 1895(1895-01-12) Bhimavaram, Andhra Pradesh, India
Died	9 August 1948(1948-08-09) (aged 53)
Nationality	Indian
Fields	Medicine
Institutions	Lederle Laboratories, a division of American Cyanamid (Acquired by Wyeth in 1994, now Pfizer)
Alma mater	Madras Medical College Harvard University
Known for	Discovery of the role of Phosphocreatine and Adenosine Triphosphate (ATP) in muscular activity Synthesis of Folic Acid Synthesis of Methotrexate Discovery of Diethylcarbamazine

Yellapragada Subbarao (Telugu: యెల్లప్రగడ సుబ్బారావు) (12 January 1895 – 9 August 1948) was an Indian biochemist who discovered the function of adenosine triphosphate as a energy source in the cell, and developed methotrexate for the treatment of cancer. Most of his career was spent in the United States. Despite his isolation of ATP, Subbarao was denied tenure at Harvard and remained without a green card throughout his life, though he would lead some of America's most important medical research during World War II.

Early life and education

He was born to a Telugu Niyogi Brahmin family in Bhimavaram of the Old Madras Presidency, now in West Godavari District, Andhra Pradesh. He passed through a traumatic period in his schooling at Rajahmundry (due to the premature death of close relations by disease) and eventually matriculated in his third attempt from the Hindu High School, Madras. He passed the Intermediate Examination from the Presidency College and entered the Madras Medical College where his education was supported by friends and Kasturi Suryanarayana Murthy, whose daughter he later married. Following Gandhi's call to boycott British goods he started wearing khadi surgical dress; this incurred the displeasure of M. C. Bradfield, his surgery professor. Consequently, though he did well in his written papers, he was awarded the lesser LMS certificate and not a full MBBS degree.

Subbarao tried to enter the Madras Medical Service without success. He then took up a job as Lecturer in Anatomy at Dr. Lakshmipathi's Ayurvedic College at Madras. He was fascinated by the healing powers of Ayurvedic medicines and began to engage in research to put Ayurveda on a modern footing.

A chance meeting with an American doctor, who was visiting on a Rockefeller Scholarship, changed his mind. The promise of support from Satyalinga Naicker Charities and Malladi Charities, Kakinada and financial assistance raised by his father-in-law, enabled Subbarao to proceed to the U.S. He arrived in Boston on 26 October 1922.

Career in America

After earning a diploma from the Harvard Medical School he joined Harvard as a junior faculty member. With Cyrus Fiske, he developed a method for the estimation of phosphorus in body fluids and tissues. He discovered the role of Phosphocreatine and Adenosine Triphosphate (ATP) in muscular activity, which earned him an entry into biochemistry textbooks in the 1930s. He obtained his Ph.D. degree the same year.

He joined Lederle Laboratories, a division of American Cyanamid (now a division of Wyeth which is owned by Pfizer), after he was denied a regular faculty position at Harvard. At Lederle, he developed a method to synthesize Folic Acid, Vitamin B₉, based on work by Lucy Wills to isolate folic acid as a ward against anemia. After his work on folic acid and with considerable inputs from Dr. Sidney Farber, he developed the important anti-cancer drug methotrexate--one of the very first cancer chemotherapy agents and still in widespread clinical use. He also discovered the drug Hetrazan which was used by the World health Organization against filariasis. Under Subbarao, Benjamin Duggar made his discovery of the world's first tetracycline antibiotic, Aureomycin, in 1945. This discovery was made as a result of the largest distributed scientific experiment ever performed to that date, when American soldiers who had fought all over the world were instructed at the end of WWII to collect soil samples from wherever they were, and bring the samples back for screening at Lederle Laboratories for possible anti-bacterial agents from natural soil fungi.

Recognition and delayed acknowledgement

Subbaro's memory has been obscured by the achievements of others and his failure to promote his own self-interest. Part of the reason for his obscurity was that Subbarao did not "market his work". A patent attorney was once astonished to find that he had not taken any of the steps that scientists everywhere consider routine for linking their name to their handiwork. He never granted interviews to the press. He never made the rounds of the academies which apportion accolades among the achievers^{[citation needed]}. He never went on lecture tours^{[citation needed]}.

His colleague, George Hitchings, who shared the 1988 Nobel Prize in Physiology or Medicine with Gertrude Elion, said, "Some of the nucleotides isolated by Subbarao had to be rediscovered years later by other workers because Fiske, apparently out of jealousy, did not let Subbarao's contributions see the light of the day."

A new fungus was named in his honor by American Cyanamid: Subbaromyces splendens.

Writing in the April 1950 issue of Argosy, Doron K. Antrim observed." , "You've probably never heard of Dr. Yellapragada SubbaRow. Yet because he lived you may be alive and are well today. Because he lived you may live longer."

External links

• ysubbarow.info
• Yellapragada SubbaRow Archives Online
• Shehjar Magazine
• The Hindu